AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 96 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,404,400 | +3963.5% | 590,000 | +6696.5% | 0.16% | +7900.0% |
| Q2 2020 | $133,000 | +75.0% | 8,681 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $76,000 | +15.2% | 8,681 | 0.0% | 0.00% | +100.0% |
| Q4 2019 | $66,000 | -99.3% | 8,681 | -99.3% | 0.00% | -99.6% |
| Q1 2018 | $9,447,000 | -51.8% | 1,295,841 | -45.8% | 0.26% | -59.2% |
| Q4 2017 | $19,613,000 | -39.7% | 2,391,841 | -22.8% | 0.65% | +4.7% |
| Q3 2017 | $32,530,000 | +106.4% | 3,098,010 | +116.8% | 0.62% | -21.7% |
| Q2 2017 | $15,763,000 | +15.6% | 1,429,114 | +1.5% | 0.79% | +2.1% |
| Q1 2017 | $13,632,000 | -5.5% | 1,408,240 | +1.4% | 0.78% | -24.3% |
| Q4 2016 | $14,424,000 | – | 1,388,240 | – | 1.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,409,289 | $24,815,676 | 12.25% |
| Knoll Capital Management, LLC | 600,000 | $6,180,000 | 6.42% |
| Vivo Capital, LLC | 4,096,428 | $42,193,208 | 4.62% |
| GENDELL JEFFREY L | 5,615,350 | $57,838,105 | 3.29% |
| Tri Locum Partners LP | 983,602 | $10,131,101 | 3.24% |
| Samsara BioCapital, LLC | 967,527 | $9,965,528 | 3.05% |
| MPM BioImpact LLC | 664,224 | $6,841,507 | 1.83% |
| COWEN AND COMPANY, LLC | 2,338,302 | $24,084,510 | 1.68% |
| RTW INVESTMENTS, LP | 7,136,415 | $73,505,075 | 1.55% |
| TANG CAPITAL MANAGEMENT LLC | 1,000,000 | $10,300,000 | 1.45% |